frequency
resumption of ovulation in premenopausal
anovulatory women
hormonal imbalance
major adverse cardiovascular events
overall data from rosiglitazone
long-term trials
record
adopt
dream trials
rosiglitazone n
control n =-rrb-
difference in overall mortality
major adverse cardiovascular events
meta-analysis of shorter-term trials
risk for myocardial infarction with rosiglitazone
placebo
record trial
rosiglitazone
cardiac outcomes
regulation of glycemia in diabetes
age years
male
significant difference in cardiovascular hospitalization
cardiovascular death
primary outcome
patients with type diabetes
receiving rosiglitazone
add-on therapy
n =-rrb-
active control
n =-rrb-
significant difference in the incidence of congestive heart failure
secondary endpoint
patients
failed metformin
sulfonylurea monotherapy
add-on rosiglitazone
active control
add-on metformin for those
sulfonylurea
add-on sulfonylurea for those
metformin
patients
target
glycosylated hemoglobin
hbac
heart failure
patients
receiving add-on rosiglitazone
patients
receiving active control
retrospective analysis of clinical trials
duration months
rosiglitazone
increased risk of myocardial ischemia
placebo control
events
angina pectoris
angina dyspnea
myocardial infarction
coronary thrombosis
myocardial ischemia
coronary artery disease
coronary artery disorder
increased risk with combination insulin therapy
patients
receiving nitrates for known coronary heart disease
cardiovascular events in patients with nyha class i
ii heart failure
increased risk of cardiovascular events
week trial in patients with nyha class i
ii heart failure
receiving rosiglitazone
n =-rrb-
placebo
n =-rrb-
events
cardiovascular deaths
worsening chf
worsening edema
worsening dyspnea
chf medication
cardiovascular hospitalization
edema
dose-related edema
rosiglitazone
clinical trials
patients
receiving rosiglitazone mg in combination with a sulfonylurea
incidence of edema
monotherapy trials
edema
patients
receiving rosiglitazone
dose
healthy volunteers
receiving rosiglitazone mg
weeks
significant increase in median plasma volume
placebo
concomitant administration with insulin
edema
higher frequency in the rosiglitazone
insulin combination trials
insulin
rosiglitazone with insulin
reports of new onset
exacerbation of congestive heart failure
rate
insulin
mg
mg
insulin in combination with rosiglitazone
coadministration of rosiglitazone
insulin
glimepiride-rosiglitazone
edema
hypertension
congestive heart failureglimepiride
edema
hypertensionrosiglitazone
edema
hypertensionuncommon
congestive heart failurefrequency
cardiovascular deaths
myocardial infarction
angina
angina pectoris
angina dyspnea
myocardial infarction
coronary thrombosis
myocardial ischemia
coronary artery disease
coronary artery disorder
glimepiride-rosiglitazone
nasopharyngitisrosiglitazone
upper
respiratory infectionpostmarketing reports
pulmonary edema
pleural effusions
glimepiride-rosiglitazone
headache
dizzinessglimepiride
headache
dizzinessrosiglitazone
headachefrequency
stroke
reported adverse reports
headache
hypoglycemia
nasopharyngitis
glimepiride
nausearare
vomiting
gastrointestinal pain
diarrhearosiglitazone
diarrhea
glimepiride
liver enzyme elevations
frequency
liver function impairment
cholestasis
jaundice
hepatitis
hepatic porphyria reactions
disulfiram-like reactionsrosiglitazone
postmarketing reports
hepatitis
hepatic enzyme elevations
times
upper limit of normal
hepatic failure
rosiglitazone
postmarketing reports
anaphylactic reaction
glimepiride
allergic skin reactions
pruritus
erythema
urticaria
morbilliform
maculopapular eruptionsfrequency
porphyria cutanea tarda
photosensitivity reactions
allergic vasculitis rosiglitazone
postmarketing reports
rash
pruritus
urticaria
angioedema
stevens-johnson syndrome
anemia
patients
receiving rosiglitazone as monotherapy
combination with metformin
sulfonylurea
metformin
sulfonylurea
incidence of anemia
laboratory findings
shown dose-related decreases in hemoglobin
hematocrit
decreases in hemoglobin
g/dl
hematocrit
changes
first months
following
dose increase
increased plasma volume
glimepiride
frequency
leukopenia
agranulocytosis
thrombocytopenia
hemolytic anemia
aplastic anemia
pancytopeniarosiglitazone
anemiafrequency
decrease in wbc counts
glimepiride-rosiglitazone
hypoglycemiafrequency
weight gainglimepiride
hypoglycemiafrequency
hyponatremia
syndrome of inappropriate antidiuretic hormone
siadh
secretion
changes in serum lipidsrosiglitazone
hypoglycemia
mechanism of weight gain
combination of fluid retention
fat accumulation
dose-related weight gain
trials with the combination glimepiride
rosiglitazone
rosiglitazone
mean weight gain in patients
combination glimepiride mg/rosiglitazone mg
kg
kg for patients
receiving glimepiride mg/rosiglitazone mg
glimepiride
blurred visionrosiglitazone
postmarketing reports
diabetic
macular edema
decreased visual acuity
rosiglitazone
common
pain
arthralgia
frequency
fractures
bone mineral density
large long-term clinical trials
increased incidence of bone fracture in patients
receiving rosiglitazone in combination with sulfonylurea
metformin as rosiglitazone
incidence
first year
majority of fractures
women
upper arm
hand
foot
glimepiride
astheniarosiglitazone
injury
body aches
pain
chills
cough
difficulty with breathing
ear congestion
fever
headache
injury
loss of voice
nasal congestion
runny nose
sneezing
sore throat
unusual tiredness
weakness
anxiety
blurred vision
chest pain
discomfort
cold sweats
coma
confusion
cool, pale skin
decreased urine output
depression
dilated neck veins
dizziness
extreme fatigue
fast heartbeat
increased hunger
irregular breathing
irregular heartbeat
nausea
nightmares
seizures
shakiness
slurred speech
swelling of the face
fingers
feet
lower legs
tightness in the chest
troubled breathing with exertion
unusual bleeding
bruising
weight gain
stomach pain
tenderness
agitation
leg
stomach pains
bleeding gums
tarry stools
blue lips
fingernails
coughing
pink frothy sputum
dark urine
decreased appetite
noisy breathing
fluid-filled skin blisters
general body swelling
hostility
increased sweating
increased thirst
irritability
itching
skin rash
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
light-colored stools
loss of appetite
muscle pain
cramps
muscle twitching
nosebleeds
pain
discomfort in the arms
jaw
neck
redness of the skin
seizures
sensitivity
sun
skin thinness
sores
ulcers
white spots on the lips
mouth
stupor
sweating
swollen glands
vomiting
yellow eyes
skin
lack
loss of strength
burning
redness of the skin
treatment
diarrhea